Ocular Implants Market Report 2026

Ocular Implants Market Overview

• Ocular Implants market size has reached to $16.25 billion in 2025 • Expected to grow to $27.69 billion in 2030 at a compound annual growth rate (CAGR) of 11.1% • Growth Driver: The Increase In Number Of Eye Surgeries Driving The Ocular Implants Market Growth Due To Rising Demand For Vision-Restoring Solutions • Market Trend: Innovative Ocular Implant Products Redefining Patient Care In The Competitive Landscape • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ocular Implants Market?

Ocular implants are used to improve the eye vision of a person. These implants help improve the fixing sight of people who have lost an eye to injury or disease, commonly called a glass eye, made up of hard plastic acrylic. The prosthetic eye has a shell form consisting of a clear, artificial lens implant used to replace a cloudy natural lens in cataract surgery. The main types of products in ocular implants are intraocular lens, corneal implants, orbital implants, glaucoma implants and others. The intraocular lens are made from chemicals or artificial substances such as clear plastic, silicone, or acrylic. It bends (refracts) light rays that enter the eye, helping one to see. They are coated with a special material that can help to protect your eyes from the harmful ultraviolet rays emitted by the sun. These ocular implants are used in glaucoma surgery, diabetic retinopathy and age-related macular degeneration by end-user such as specialty eye institutes, hospitals and clinics.

What Is The Ocular Implants Market Growth Forecast?

The ocular implants market size is expected to see rapid growth in the next few years. It will grow to $27.69 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing adoption of premium iol solutions, rising demand for vision correction procedures, expansion of specialty eye care infrastructure, growing focus on patient-specific implants, continued advancements in ophthalmic biomaterials. Major trends in the forecast period include increasing adoption of advanced intraocular lens designs, rising use of minimally invasive glaucoma implants, growing demand for customized ocular prosthetics, expansion of biocompatible implant materials, enhanced focus on long-term implant durability.

Global Ocular Implants Market Segmentation

1) By Product: Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants 2) By Application: Cataract Surgery, Glaucoma Management And Surgery, Corneal Disorders And Keratoconus Treatment, Ocular Trauma And Eye Loss Management, Refractive Vision Correction 3) By End-User: Specialty Eye Institutes, Hospitals, Clinics Subsegments: 1) By Intraocular Lens (IOL): Monofocal IOL, Multifocal IOL, Toric IOL, Accommodative IOL 2) By Corneal Implants: Synthetic Corneal Implants, Donor Corneal Implants, Intracorneal Ring Segments (ICRS) 3) By Orbital Implants: Porous Orbital Implants, Non-Porous Orbital Implants 4) By Glaucoma Implants: Aqueous Shunts Or Valves, Micro-Invasive Glaucoma Surgery (MIGS) Devices

What Is The Driver Of The Ocular Implants Market?

The increase in number of eye surgeries is expected to propel the growth of the ocular implants market going forward. Eye surgeries refer to medical procedures performed on the eye to treat vision problems, correct refractive errors, or manage eye diseases such as cataracts, glaucoma, or retinal disorders. The number of eye surgeries is rising due to aging populations in developed countries, which leads to a higher prevalence of age-related eye conditions such as cataracts and glaucoma that require surgical treatment. Ocular implants play a crucial role in eye surgeries by replacing or supporting the natural lens or other eye structures, thereby restoring vision and improving surgical outcomes for patients undergoing procedures such as cataract or corneal surgeries. For instance, in 2023, according to the Eye Bank Association of America, a US-based transplant association, domestic keratoplasty procedures grew by 2.7%, increasing from 49,597 in 2022 to 50,925 in 2023. Therefore, the increase in number of eye surgeries is driving the growth of the ocular implants industry.

Key Players In The Global Ocular Implants Market

Major companies operating in the ocular implants market are Alcon Inc., Bausch & Lomb Inc., Carl Zeiss AG, STAAR Surgical Company, Johnson and Johnson Services Inc., Morcher GmbH, Aurolab Ltd., Cornea Biosciences, KERAMED INC., Price Vision Group, Gulden Ophthalmics Co. Inc., AJL Ophthalmic SA, Hoya Corp., Rayner Intraocular Lenses Limited, Lenstec Inc., SIFI S.p.A, Ophtec BV, HumanOptics AG, Medicontur Medical Engineering Ltd., Hanita Lenses, Omni Lens Pvt. Ltd., EyeKon Medical Inc., FCI Ophthalmics Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., AcuFocus Inc., Glaukos Corporation, Ivantis Inc.

Global Ocular Implants Market Trends and Insights

Major companies operating in the ocular implant market are introducing innovative and premium-quality iris implant products, such as artificialiris select, to gain a competitive advantage. Artificialiris select is a premium implant offering expedited and customizable iris replacement for enhanced patient care. For instance, in August 2023, HumanOptics Holding AG, a Germany-based medical technology manufacturer, will launch the premium implant ARTIFICIALIRIS SELECT. It offers a range of color choices, including brown, blue, and green, each available in three different shades, such as light, medium, and dark. The implant is readily available in nine predefined color combinations, ensuring quick and efficient patient care. Surgeons can easily select the most appropriate color match for the patient by using the specially designed HumanOptics color chart select and comparing it to the patient's healthy eye.

What Are Latest Mergers And Acquisitions In The Ocular Implants Market?

In June 2024, ANI Pharmaceuticals, Inc., a US-based pharmaceutical company, acquired Alimera Sciences, Inc., for an undisclosed amount. Through this acquisition, ANI Pharmaceuticals aims to bolster its rare disease segment and ophthalmology portfolio, gaining two commercially viable assets, Iluvien and Yutiq, which are expected to drive significant revenue growth and enhance ANI's global presence in the ophthalmology market. Alimera Sciences, Inc., a US-based pharmaceutical company, offers intravitreal (back of the eye) implants.

Regional Outlook

North America was the largest region in the ocular implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ocular Implants Market?

The ocular implants market consists of sales of monofocal lens, toric lens, multifocal and accommodating lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.